Teresa DeLuca

Teresa DeLuca (board member) discloses dealings in 3 companies, chiefly Surgery Partners, Inc., LifeStance Health Group, Inc. and FORUM MARKETS Inc. We count 20 filings; the first trade dates from 8 June 2021 and the latest from 18 August 2026.

Both buying and selling appear: 5 purchases worth €835k, against 6 sales worth €1.2M. Sales outweigh purchases by €331k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 9 share grants. Since January 2026: 2 purchases and 2 sales on the market.

A typical purchase (the median) is worth €124k. Of 5 purchases, 2 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 20 August 2026 came the latest disclosure, an open-market purchase for €139k in Surgery Partners, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.